Skip to main content
Equibles

JACOBS LEVY EQUITY MANAGEMENT, INC

Position in MGNX — Macrogenics Inc

CIK 884414 FLORHAM PARK, NJ
Back to MGNX Full portfolio

Position in MGNX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,630,505
+$3,355,602 QoQ
Shares Held
1,002,274
+127.2% QoQ
Ownership
1.57%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#17
of 122 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $740,535,030 across 80 Biotechnology names. MGNX ranks #27 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 256,503 $159,939,880
2 RARE
Ultragenyx Pharmaceutical Inc.
 2,939,719 $98,157,217
3 INCY
Incyte Corp
 731,774 $82,953,900
4 CORT
Corcept Therapeutics Inc
 695,532 $60,476,507
5 HALO
Halozyme Therapeutics, Inc.
 322,377 $25,232,447
6 EXEL
Exelixis, Inc.
 415,650 $22,615,516
7 AUPH
Aurinia Pharmaceuticals Inc.
 1,231,516 $20,898,826
8 ALNY
Alnylam Pharmaceuticals, Inc.
 60,986 $18,358,615

All Filings in MGNX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,630,505 1,002,274
2026-03-31 $1,274,903 441,143
2025-12-31 $1,450,701 901,057
2025-09-30 $1,370,653 815,865
2025-06-30 $1,215,805 1,004,798
2025-03-31 $844,995 665,351
2024-12-31 $1,839,188 565,904
2024-09-30 $1,863,219 566,328
2024-06-30 $1,780,282 418,890
2024-03-31 $2,178,824 148,018
2023-12-31 $1,106,097 114,979
2023-09-30 $1,861,595 399,484
2023-06-30 $2,166,675 404,986
2023-03-31 $2,180,554 304,122
2022-12-31 $373,988 55,736
2022-06-30 $210,110 71,224
2022-03-31 $1,482,053 168,224
2020-09-30 $465,611 18,484
2020-06-30 $5,880,957 210,636
2020-03-31 $1,294,629 222,445